Definitive Contract 75D30120C07995
Award Date 4/29/20
Potential Completion Date 4/28/21
Potential Value $856K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lexington, MA 02420, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded a $14 million firm fixed price delivery order contract to Quest Diagnostics Incorporated for surge serology testing services. Under the contract, Quest Diagnostics will provide COVID-19 antibody testing from its laboratory located in Secaucus, New Jersey to support the CDC's pandemic response efforts. The period of performance is from July 30, 2020 through November 19, 2020. No set aside designation or subcontractors were identified....
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh to Domestic Awardees (Undisclosed), a for-profit organization doing business as the Federal Egov IAE Initiative - Generic Entity Identifier. The $98,550.00 Firm Fixed Price contract is for the provision of serum for PCR positive COVID-19 donors, in support of the Coronavirus COVID-19 national interest action. The contract does not have a set-aside designation and has an ultimate...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Definitive Contract to Bioivt, LLC, a for-profit limited liability company, to provide COVID-19 positive blood serum. The Firm Fixed Price contract, valued at $370,350.00, has a completion date of April 28, 2021. Bioivt, LLC is a leading global provider of high-quality biological specimens and has previously supported various medical research programs across federal agencies, including the Defense...
- The Centers for Disease Control and Prevention (CDC) awarded a $728,000 firm fixed price definitive contract to Quest Diagnostics Incorporated for de-identified specimen remnants to support the National Center for Immunization and Respiratory Diseases (NCIRD). As the prime contractor, Quest Diagnostics will provide de-identified biological specimens to NCIRD through April 2021. No subcontractors or set aside designations were indicated. NCIRD conducts public health surveillance, laboratory...
- This is a $47,916,380.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Laboratory Corporation of America (Labcorp) for serology testing services. The contract has a firm fixed price pricing type and a period of performance through March 5, 2022. The original solicitation was a pre-solicitation for laboratory testing of blood specimens to determine SARS-CoV-2 seroprevalence across the United States. The contract supports the CDC's public health initiatives...
- The Centers for Disease Control and Prevention awarded a $2.8 million firm fixed price contract to Laboratory Corporation of America, operating as Labcorp, to provide residual blood specimen collection and SARS-CoV-2 serology testing services under the Multistate Assessment of SARS-CoV-2 Seroprevalence study. Labcorp will collect approximately 33,800 residual sera samples per month from all 50 states, Washington D.C. and Puerto Rico, distributed by age, and test for SARS-CoV-2 nucleocapsid...
- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Solomon Park Research Laboratories, Inc., a veteran-owned business and manufacturer of goods, for the provision of bulk serum, whole units of serum, and pooled serum. This $174,820.80 contract supports the CDC's disease testing and research efforts related to the development of laboratory standards. The contract was awarded on April 11, 2019...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to XCR Diagnostics, Inc., a manufacturer of goods focused on molecular diagnostics testing. The $147,000.00 contract is for the delivery of CBOT singleplex assays, laboratory supplies, and reagents to support the CDC's diagnostic testing capabilities in Pittsburgh, Pennsylvania and Atlanta, Georgia. The contract has a completion date of August 1, 2019...
- This is a $93,600 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a leading provider of clinical laboratory services. The contract is for the delivery of de-identified nasopharyngeal specimens, with a period of performance through August 13, 2026. This award does not have a set-aside designation. Quest Diagnostics has a long history of supporting federal agencies, including providing lab services for the CDC's...
- XCR Diagnostics, Inc., a subsidiary of Fluoresentric, Inc., has been awarded a purchase order contract valued at two hundred eleven thousand seven hundred seventy-one dollars by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of a singleplex CBOT A assay to CDC's facility in Atlanta, Georgia. The firm fixed price contract runs from September 12, 2023 through October 30, 2023. No set aside designation or subcontractors...